Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions by Buzón Redorta, Victor et al.
Crystal Structure of HIV-1 gp41 Including Both Fusion
Peptide and Membrane Proximal External Regions
Victor Buzon1., Ganesh Natrajan1., David Schibli1¤, Felix Campelo2, Michael M. Kozlov2, Winfried
Weissenhorn1*
1 Unit of Virus Host Cell Interactions (UVHCI) UMI 3265 Universite´ Joseph Fourier-EMBL-CNRS, Grenoble, France, 2 Department of Physiology and Pharmacology, Sackler
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Abstract
The HIV-1 envelope glycoprotein (Env) composed of the receptor binding domain gp120 and the fusion protein subunit
gp41 catalyzes virus entry and is a major target for therapeutic intervention and for neutralizing antibodies. Env interactions
with cellular receptors trigger refolding of gp41, which induces close apposition of viral and cellular membranes leading to
membrane fusion. The energy released during refolding is used to overcome the kinetic barrier and drives the fusion
reaction. Here, we report the crystal structure at 2 A˚ resolution of the complete extracellular domain of gp41 lacking the
fusion peptide and the cystein-linked loop. Both the fusion peptide proximal region (FPPR) and the membrane proximal
external region (MPER) form helical extensions from the gp41 six-helical bundle core structure. The lack of regular coiled-coil
interactions within FPPR and MPER splay this end of the structure apart while positioning the fusion peptide towards the
outside of the six-helical bundle and exposing conserved hydrophobic MPER residues. Unexpectedly, the section of the
MPER, which is juxtaposed to the transmembrane region (TMR), bends in a 90u-angle sideward positioning three aromatic
side chains per monomer for membrane insertion. We calculate that this structural motif might facilitate the generation of
membrane curvature on the viral membrane. The presence of FPPR and MPER increases the melting temperature of gp41
significantly in comparison to the core structure of gp41. Thus, our data indicate that the ordered assembly of FPPR and
MPER beyond the core contributes energy to the membrane fusion reaction. Furthermore, we provide the first structural
evidence that part of MPER will be membrane inserted within trimeric gp41. We propose that this framework has important
implications for membrane bending on the viral membrane, which is required for fusion and could provide a platform for
epitope and lipid bilayer recognition for broadly neutralizing gp41 antibodies.
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Introduction
HIV-1 employs its trimeric env glycoprotein, composed of the
receptor binding domain gp120 and the membrane anchored
fusion protein subunit gp41 to enter host cells. Gp120 interacts
sequentially with its cellular receptors CD4 and coreceptor CCR5
or CXCR4 [1], which induce a cascade of conformational changes
in gp120 and gp41 [2,3]. As a consequence the core of gp41 folds
into a six helical bundle structure that leads to the apposition of
viral and cellular membranes [4,5].
Gp41 catalyses membrane fusion and current models suggest
that receptor binding leads to the exposure of the gp41 fusion
peptide (FP), which interacts with the target cell membrane
producing an intermediate, pre-hairpin state bridging two
membranes. This pre-hairpin has a relatively long half-life [6]
and constitutes the target for inhibitory peptides [7,8,9] and
neutralizing antibodies directed against HR1 [10][11] and MPER
[12,13]. Potentially at this stage, MPER was hypothesized to be
membrane embedded based on the reactivity of broadly
neutralizing MPER-specific antibodies [14,15,16,17,18]. The
pre-hairpin then refolds into the six-helix bundle core structure
[4,5] and it is this transition that catalyzes membrane fusion [19].
Six-helix bundle core formation is achieved before fusion pore
opening [20]. Experimental evidence [6,19,21] suggest that fusion
proceeds via lipidic intermediate states, a membrane stalk, opening
of the fusion pore and its expansion [22]. Mutagenesis analyses
indicate that both linkers to the membrane anchors, FPPR and
MPER, are implicated in fusion [23,24] and the TMRs play an
important role in fusion pore enlargement [22,25,26].
The energy released during gp41 refolding is used to overcome the
kinetic barrier [3,27], which is underlined by the high thermostability
of gp41 core structures [28,29] constituting a common feature of viral
fusion proteins [30][31][32][26]. Although the free energy liberated
during refolding of one trimer might be sufficient for fusion [26]
consistent with experimental evidence [33], other studies imply that
cooperativity of several trimers is required [34].
PLoS Pathogens | www.plospathogens.org 1 May 2010 | Volume 6 | Issue 5 | e1000880
In order to understand the structural basis of MPER and FPPR
in the context of gp41 trimers and their potential contribution to
stabilize the gp41 post fusion conformation, we have assembled
gp41 containing FPPR and MPER (gp41528–683). Thermostability
measurements show that inclusion of FPPR and MPER increases
the melting temperature (Tm) substantially compared to the gp41
core, suggesting that the gain of free energy can be directly
coupled to membrane fusion. The crystal structure of gp41528–683
shows helical refolding of FPPR and part of MPER as well as the
potential membrane insertion of MPER adjacent to the TMR.
The structure thus indicates for the first time that part of MPER
can insert into the viral membrane within trimeric gp41 and
supports the hypothesis that a number of neutralizing gp41
antibodies recognize MPER in a membrane environment.
Results
Thermal denaturation of the extracellular domain of
gp41
We assembled the extracellular domain of gp41 from two
fragments containing residues 528 (lacking 16 N-terminal gp41
residues including FP) to 581 (FPPR-heptad repeat 1, HR1) and
residues 629 to 683 (HR2-MPER) (gp41528–683) (Fig. 1A and Fig.
S1). Both chains contain N-terminal Flag-tags to produce a soluble
and monodisperse complex (Fig. S2). Circular dichroism analysis
reveals a high helical content of ,90% (Fig. S3A) and a melting
temperature (Tm) of 87.6uC (Fig. 1B). In comparison, the core
fragment of gp41 composed of HR1 and HR2 [5] (gp41541–665)
containing N-terminal Flag-tags shows a Tm of 75.1uC (Fig. 1B).
Thus FPPR and MPER interact and impart most likely increased
trimer stability.
Crystal structure of gp41 and MPER membrane insertion
Gp41528–683 was crystallized in space group P63. The structure
was solved by molecular replacement and refined to a resolution of
2 A˚ (Table 1). The crystal structure composed of residues 531–581
and 629–681 plus 5 N-terminal Flag-tag residues reveals the six
helical bundle core [4,5] with FPPR and MPER extending in a
helical conformation resulting in an 88 A˚-long rod-like structure
(Fig. 2A). A striking feature of the structure is a ,90u turn of the
MPER chain at Asn 677 which positions the remaining residues
including Trp 678, Trp 680 and Tyr 681 perpendicular to the rod
(Fig. 2B). Two disordered C-terminal residues must connect gp41
into the TMR in the membrane (Fig. S4). As a consequence, Trp
678, Trp 680 and Tyr 681 are exposed towards the membrane
and well positioned to insert their side chains into the bilayer (Fig.
S4). In order to calculate the membrane curvature generated by a
shallow embedding of these MPER residues into the outer leaflet
Figure 1. FPPR and MPER increase the melting temperature of
gp41. A) Schematic overview of gp41; FP, fusion peptide; FPPR, fusion
peptide proximal region; HR1, heptad repeat 1; HR2, heptad repeat 2;
MPER, membrane proximal external region; TMR, transmembrane
region. B) Unfolding of gp41528–683 and gp41541–665 monitored by
circular dichroism spectroscopy at 222 nm.
doi:10.1371/journal.ppat.1000880.g001
Author Summary
HIV-1 employs its envelope glycoprotein complex (Env)
composed of gp120 and gp41 to catalyze cell entry. Both
Env subunits undergo conformational changes triggered
by the gp120-mediated interactions with cellular recep-
tors. Notably, gp41 refolds into a core six-helical bundle
structure which is central to the fusion process. Here we
report the structural basis for the folding of the linker
regions connecting to the membrane anchors of gp41,
namely to the transmembrane region (MPER) and to the
fusion peptide (FPPR). Our structural analysis shows helical
assemblies of FPPR and MPER which increase the melting
temperature of gp41 and position the fusion peptide
towards the outside of the six-helix bundle structure at this
stage of gp41 refolding. It suggests that part of MPER must
be inserted into the viral membrane, which would induce
membrane curvature as postulated to be required for the
fusion reaction. Thus our findings shed new light on the
refolding of gp41, which contributes energy to the fusion
reaction and reveals for the first time the structural
principles of MPER membrane interaction within trimeric
gp41. We propose that the structure presents a late fusion
intermediate state that provides a new framework for
fusion inhibitor development and MPER immunogen
design.
Table 1. Crystallographic statistics.
Data collection statistics
Resolution(A˚) 91.00 - 2.00 (2.11 – 2.00)
Completeness(%) 96.5 (84.0)
I/s(I) 17.9 (2.8)
Rmerge 0.065 (0.331)
Redundancy 5.9 (2.4)
Number of reflections 129,367 (6627)
Unique reflections 22,184 (2804)
Refinement statistics
Resolution range (A˚) 50.00 – 2.00
Rwork 0.177
Rfree 0.217
R.m.s.d (bonds)(A˚) 0.009
R.m.s.d (angles)(u) 1.242
No of atoms 2405
No of waters 60
doi:10.1371/journal.ppat.1000880.t001
Structure of gp41 with MPER and FPPR
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of a bilayer, we used a model for membrane bending by
hydrophobic insertions [35]. This suggests that one gp41 chain
produces local curvature of ,0.65 nm21; thus a gp41 trimer
might stabilize a membrane cylinder of about 15 nm diameter,
which would facilitate fusion considerably [36].
Structure of FPPR and MPER
Both FPPR and MPER extend HR1 and HR2 as continuous
helices, but neither extension shows the regular knobs into holes
packing reminiscent of classical coiled coils. Instead the FPPR
region splays the inner core apart starting from Leu 545 (a position)
(Fig. 3A). The distance between Arg 579 residues at the HR1 C-
terminus is 12.5 A˚ while the one at the extreme N-terminus opens
up to 22.7 A˚ (between Gly residues 531). As a consequence HR1
heptad positions are too far apart for interaction (Fig. 3A). The
FPPR-MPER region is only stabilized by few hydrophobic contacts
between adjacent chains, including interactions of Gly 531- Leu679,
Ala 533- Trp 670, Met 535-Ile 675/Asn 671, Thr 536/Leu 537 -
Trp 666 and one hydrogen bond between the carbonyl of Ala 533
and NE1 of Trp 670 (Fig. 3B). At position of MPER residue Asn
676, the N-terminus of FPPR-HR1 points towards the outside of the
rod (Fig. 2A) facilitating fusion peptide (residues 512–530)
membrane interaction or further refolding of FP with MPER and
possibly TMR. Another striking feature of the structure is the
solvent exposure of a stretch of hydrophobic MPER residues (Trp
666, Leu 669, Trp670, Trp 672, Phe 673) that generate a
hydrophobic surface patch (Fig. S5).
Figure 2. Crystal structure of gp41528–683 reveals a 90 A˚ long
rod-like structure. A) Ribbon representation of gp41. The previously
determined core is colored dark blue (HR1) and marine blue (HR2). The
flag sequence present at the N-terminus of HR2 is shown in black. FPPR
is colored in light blue and MPER in grey. Note that the N-terminus of
FPPR (residue 531) points towards the outside of the rod. B) Close up of
the MPER and FPPR region shows the exposure of aromatic side chains
Trp 678, Trp 680 and Tyr 681 towards the membrane.
doi:10.1371/journal.ppat.1000880.g002
Figure 3. The FPPR-MPER regions are splayed apart. A) Close-up
view from the bottom showing residue Leu 545 as the last coiled coil
interacting residue of the HR1 core of gp41. The preceding potential
heptad positions are Ala 541 and Thr 538. B) Close up view revealing
mostly hydrophobic interactions between FPPR and MPER and only one
hydrogen bond between the carbonyl of Ala and NE1 of Trp 670. C)
Close-up of solvent exposed hydrophobic MPER residues.
doi:10.1371/journal.ppat.1000880.g003
Structure of gp41 with MPER and FPPR
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Since the crystals were grown at a high MPD concentration, we
tested the effect of MPD on the structure in solution. MPD does
not change the overall helical content of gp41528–683, which is
,90% in the absence and presence of high MPD concentrations
(Fig. S3A). However, MPD reduced the Tm of gp41528–683 to
82.2uC (5% MPD) and 74.7uC (10% MPD) as well as that of the
gp41541–665 core (Fig. S3B). Therefore, we cannot exclude the
possibility that MPD might have destabilized the rod resulting in
the ‘open’ structure (Fig. 3A) and FPPR and MPER might pack
tighter in the absence of MPD.
Comparison of MPER conformations
The NMR structures of MPER peptides show kinked or straight
helical conformations [17,37], which superimpose partly with
MPER present in the crystal structure (Fig. S6A and B). Three
broadly neutralizing antibodies (nAb) target MPER and utilize
diverse structural motifs for recognition. NAb 2F5 recognizes a
beta-hairpin [15] and Z13e1 binds to a short kinked helix [38].
Both epitopes refold into a straight helix in the gp41 structure
(Fig. 4A and B). The epitope of nAb 4E10 is helical [16]; although
it is present and exposed in the gp41 crystal structure (Fig. 4C)
nAb 4E10 does not interact with gp41528–683 (data not shown), due
to clashes with the helical conformation of HR2. However, if we
consider only MPER and its membrane orientation and dock the
4E10 structure onto its epitope, nAb 4E10 could present its heavy
chain CDR3 loop implicated in bilayer interaction [14,18]
towards the membrane, lined up with the gp41 membrane
embedded residues W678, W680 and Y681 (Fig. S7). The
comparison of the peptide epitope structures and gp41 corroborate
that nAbs 2F5 and Z13e1 block the refolding process of gp41 at
early steps. In contrast the 4E10 epitope might be present
throughout gp41 refolding from a native conformation as evident
by its presence in the late fusion intermediate conformation.
Discussion
Although the core structure of the HIV-1 fusion protein has
been solved [4,5], detailed structural information on the regions
linking up to the membrane anchors (FPPR and MPER) has been
lacking. We crystallized gp41(528–683), which has a similar N-
terminal end as a proteolytic fragment of HIV-2 gp41 [39] and N-
and C-terminal ends as determined by peptide studies [40] and
solved its structure. FPPR and most of MPER extend in a helical
fashion from the gp41 core and interact with each other as
indicated by peptide studies performed at pH 3.2 [40]. Although
the interactions are mostly hydrophobic, they are not classical
coiled-coil interactions. The TMR-juxtaposed region of MPER
positions three aromatic side chains per monomer towards the
membrane. We calculate that membrane insertion of these
residues could induce membrane curvature in the outer leaflet of
the viral lipid bilayer [35], which would facilitate fusion based on
previous studies [36]. Membrane fusion models postulate that
fusion proteins induce local bending of both bilayers into ‘‘nipples’’
projecting toward each other to reduce the energy requirement for
initial stalk formation [22,41,42]. Bending on the target-cell side
can be stabilized by insertion of the fusion peptide [43] or
hydrophobic residues of fusion loops [26]. The present structure
suggests that bending on the viral side may be stabilized by
membrane-embedded MPER residues. We suggest that MPER
membrane insertion may occur early during the conformational
transition of gp41 and persist through the process of refolding.
Alternatively this segment of MPER may adopt a straight helical
conformation [37] in continuity with TMR in the final postfusion
conformation. Such a continuous helical structure was observed
for the linker sequences that connect the core SNARE complex to
its TMRs [44].
The presence of FPPR and MPER splay the ‘‘membrane-
anchor’’ end of the rod apart, which may be required to
accommodate FP whose chain direction points to the exterior of
the structure. The missing part of FP (residues 512–530) could thus
contact the membrane and/or interact with the kinked membrane
embedded MPER or with a straight helical MPER conformation.
Since the thermostability measurements indicate that the MPD
crystallization conditions could influence the stability of gp41 in
solution, it is possible that FPPR and MPER pack tighter in the
absence of MPD. We thus propose that the structure represents a
late fusion intermediate state rather than the final postfusion
conformation, although the latter possibility cannot be excluded.
MPER contains a number of hydrophobic residues, which are
conserved in the majority of HIV and SIV isolates, namely
Trp666, Trp672, Phe673 and Ile675. Single Ala mutations of
these residues do not affect cell-cell fusion but reduce viral
infectivity significantly [24]. Interestingly all residues are mostly
exposed in the crystal structure and/or contribute to hydrophobic
interactions with FPPR. Mutation of FPPR Leu537, which makes
a hydrophobic contact with Trp666, in combination with
mutations of conserved MPER residues Trp666 or Trp672 or
Phe673 or Ile675, reduces virus infectivity further thus confirming
Figure 4. Comparison of MPER conformations. MPER conformations as determined in complex with broadly neutralizing antibodies (A) 2F5
[15], (B) Z13e1 [38] and (C) 4E10 [16] are shown in comparison to MPER within trimeric gp41. The corresponding MPER segments are colored equally
and residues contacting the 4E10 Fab are shown as sticks. (blue, HR2).
doi:10.1371/journal.ppat.1000880.g004
Structure of gp41 with MPER and FPPR
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the important interplay between FPPR and MPER during fusion
[24]. Analysis showed that the defect of mutant Leu537-Trp666 is
at the level of lipid mixing [24]. Another study demonstrated that
mutations of the five conserved tryptophan residues (Trp666,
Trp670, Trp 672, Trp678, Trp680) alone or in combination or
deletion mutants within MPER affect syncytium formation thus
supporting the importance of MPER for fusion [45]. Reduction in
viral infectivity was also reported for pseudoviruses containing
alanine mutations of hydrophobic MPER residues (Leu 669,
Ile675, Leu679) exposed within MPER in addition to the
conserved tryptophan residues [46]. The hydrophobic surface
generated by the conserved MPER residues as shown here might
induce clustering of several gp41 trimers at the site of fusion
although the number of env trimers required for fusion is still
debated [33,34]. Such a function may be consistent with
mutagenesis data showing that single tryptophan exchanges within
MPER affect cell-cell fusion, while combinations of tryptophan
mutations abrogate cell-cell fusion completely [45]. Thus muta-
genesis of multiple tryptophans may reduce the hydrophobicity of
the exposed patch sufficiently to affect the clustering function.
Six-helix bundle formation leads to fusion pore opening [20]
and an intact six-helix bundle is required for its enlargement [47].
Since FPPR and MPER folding most likely follows six-helix
bundle formation its hydrophobic patch may further support pore
enlargement together with the essential role of TMRs [22,25,26].
This suggestion is in agreement with data on mutagenesis of all 5
tryptophan residues within MPER; these mutations do not affect
fusion pore opening, but inhibit fusion pore expansion [23].
Finally the linker region that connects the SNARE complex with
its TMR exposes a similar patch of hydrophobic residues [44]
underlining functional similarities between viral fusion protein and
SNARE-mediated membrane fusion processes.
Fusion proteins utilize the free energy released during their
refolding to draw two membranes into close apposition and catalyze
membrane fusion [26]. The thermostability measurement of the
gp41 core compared to the crystal structure reveals a 12uC increase
of the melting temperature, which can translate into an increase in
DG that can be directly coupled to membrane fusion. Notably,
folding of the complete SNARE complex versus the core produces a
similar increase in Tm that can convert into energy for fusion [44].
MPER harbors the epitopes of three broadly neutralizing
antibodies, 2F5, Z13e1 and 4E10. The epitopes of 2F5 and Z13e1
[15,38] adopt a straight helical conformation, indicating that both
antibodies neutralize by blocking the transition into the trimeric
gp41 structure. In contrast the epitope of 4E10 [16] is still present
and exposed, although nAb 4E10 does not interact with
gp41528–683 due to clashes with the helical conformation of
HR2. NAb 4E10 has a long CDR3 region that does not contact
the epitope, but was proposed to interact with the membrane [16]
based on its reactivity with lipids [14]. If we consider only the
4E10 epitope and the membrane embedded part of MPER, 4E10
could orient its CDR3 towards the membrane and insert its
aromatic residues into the bilayer as required for neutralization
[18]. Thus stabilization of a peptide in the conformation of the
MPER as present in the crystal structure should prove useful to
generate an immunogen capable of inducing 4E10-like antibody
responses.
Based on the crystal structure we suggest the following extension
to our picture of the fusion process. Receptor binding induced
conformational changes exposes FP, which interacts and bends the
target cell membrane. Concomitantly, TMR and MPER dissoci-
ate, potentially from a native MPER coiled-coil structure [48] and
a few aromatic MPER residues insert into and bend the outer
leaflet of the viral membrane. This then generates the functional
epitope for nAb 4E10. Part of MPER stays membrane associated
throughout the folding of the gp41 core that leads to fusion pore
opening. Subsequently FPPR and the soluble part of MPER
interact, releasing more energy for fusion. Alternatively, we cannot
exclude the possibilities that (i) membrane insertion of MPER is
already present in the native env trimer or (ii) that membrane
insertion of MPER is not important for the generation of
membrane curvature and exerts another role during the fusion
process. Finally, although the conformational state of gp41
observed in the crystal structure is no longer targeted by
neutralizing antibodies, the development of small molecules
targeting the FPPR-MPER conformation could block further
gp41 refolding required for membrane fusion.
Materials and Methods
Protein constructs
The gp41 proteins were assembled from different fragments of
gp41 (Fig. S1): FPPR-HR1-HR2-MPER (Ser528 to Leu581 and
Met628 to Lys683; gp41528–683), HR1-HR2 (Ala
541 to Leu581 and
Met628 to Lys665; gp41541–665). DNA sequencing and MALDI
TOF Mass Spectrometry confirmed all constructs.
Protein expression and purification
Fragments of HIV-1 gp41 HXB2 group M subtype B were
amplified by standard PCR techniques and cloned either into
pETM-MBP-1a (EMBL, Heidelberg), pETM-20 (thioredoxin
fusion, EMBL, Heidelberg) or pET11 (His-tag). HR1 and HR2
containing constructs were N-terminally fused to the Flag-tag
sequence (ASP-ASP-ASP-ASP-Lys) to improve solubility (Fig. S1).
Gp41528–683 and gp41541–665 fusion proteins were expressed in
E. coli strain Rosetta 3 (DE3) (Strategene). Cells were grown to an
OD600 nm of 0.7 and induced with 1 mM IPTG at 37uC. After
2 hours cells were harvested by centrifugation, resuspended in
buffer A (0.02 M Tris pH 8.0, 0.1 M NaCl) and pellets of HR1
and HR2 expressing bacteria were mixed before lysis. Notably,
bacteria expressing HR2 were used in excess over HR1 expressing
bacteria. The soluble fraction was loaded onto an amylose column
(NEB) and eluted in buffer A with 0.01 M maltose. In order to
remove fusion proteins, constructs were digested o. n. at 4 Cu with
TEV (Tobbacco Etch Protease) and the uncleaved material was
removed by Ni2+ chromatography. Further purification was
achieved by anionic exchange chromatography in buffer A. A
final purification step included size exclusion chromatography on a
superdex 200 column in buffer A.
Crystallization, data collection and structure
determination
Crystals of gp41528–683 were obtained by the vapor diffusion
method in hanging drops mixing equal volumes of purified
complex and reservoir solution (0.1 M citric acid pH 6, 60% MPD
(v/v)). Crystals were improved by macroseeding; briefly crystals
grown in the initial conditions (0.1 M citric acid pH 6, 60% MPD
(v/v)) were transferred into a new drop equilibrated with 0.1 M
citric acid pH 6, 56% MPD (v/v), 1.5% glycerol (v/v). Before data
collection, crystals were flash frozen at 100 K using the same
reservoir solution supplemented with 10% of glycerol (v/v).
A dataset was collected at the ESRF beam line ID14-EH4 at
100 K. The images were indexed with MOSFLM [49] and scaled
with SCALA [50,51]. The crystals were twinned and analysis with
phenix.xtriage [52] revealed space group P63 with twin fractions of
0.45 (Britton) and 0.47 (H test and Maximum likelihood test) and
an associated twin law of h, -h-k, -l. The cell parameters are
a = b = 57.42 A˚, c = 182.76 A˚, a= b= 90u, c= 120u. The struc-
Structure of gp41 with MPER and FPPR
PLoS Pathogens | www.plospathogens.org 5 May 2010 | Volume 6 | Issue 5 | e1000880
ture was solved by molecular replacement using the program
Phaser [53] and the model of the gp41 core (PDB ID: 1AIK) by
applying the twin law of h, -h-k, -l on the data, revealing 3
molecules in the asymmetric unit. The model was built manually
with COOT [54] and refined with the program Phenix [52]. The
final structure has an Rfactor of 0.177 and Rfree of 0.217 and good
stereochemistry (Table 1). The most complete monomer contains
gp41 residues 531–581 and gp41 residues 629–681 plus 5 N-
terminal residues (624-DDDDK-628 derived from the Flag/
enterokinase cleavage site sequence); this monomer was used to
reconstruct the trimer by applying crystallographic symmetry. The
second monomer contains residues 538–581 and 629–672 plus 5
N-terminal residues (residues 624-DDDDK-628); the third
monomer contains residues 542–580 and 629–665 plus 5 N-
terminal residues (residues 623-MDDDDK-628). All molecular
graphics figures were generated with Pymol (http://www.pymol.
org). Coordinates and structure factors have been deposited in the
protein data bank with accession number 267r.
CD spectroscopy
CD measurements were performed using a JASCO Spectropo-
larimeter equipped with a thermoelectric temperature controller.
Spectra of each protein were recorded at 20uC in 1 nm steps from
190 to 260 nm in buffer A or buffer A supplemented with MPD as
indicated. Spectra were recorded at 222 nm using a bandwidth of
4 nm and averaging time of 4 sec per step. For thermal
denaturation experiments, the ellipticity was recorded at 222 nm
with 1uC steps from 20u to 100uC with an increment of 80uC h21
and an averaging time of 30 s/step. Since the unfolding of
gp41528–683 was not reversible, two more spectra were recorded
with increments of 40uC h21 and 120uC h21, which resulted in
comparable Tms, indicating that the system was in equilibrium.
For data analysis, spectra were corrected for the baseline (recorded
with buffer) and the raw ellipticity values were converted to mean
residue ellipticity. Thermal melting (Tm) points were calculated
with a Boltzmann sigmoid fit using the program OriginLab.
Physical model
The effective shape of a membrane embedding domain
consisting of the gp41 hydrophobic residues was approximated
by a short cylindrical rod of 16 A˚ in length and 7 A˚ in diameter,
shallowly inserted up to a 5 A˚ depth into the outer membrane
monolayer (the insertion volume constituting 468.9 A˚3). According
to the previously developed model of membrane bending by
hydrophobic insertions [35] the effective spontaneous curvature of
such an insertion equals f*0:65 nm{1. The overall membrane
curvature generated by the insertions is proportional to their area
fraction in the membrane plane whose maximal value is limited by
a dense packing of the proteins on the membrane surface. For a
gp41 trimer the area of each of the three inserted side chains is
16 A˚67 A˚ = 112 A˚2, while the total area of the trimer projection
on the membrane plane is determined by the dimensions of the
ectodomains and constitutes, approximately, 800 A˚2. Taking into
account these numbers, we obtain that a maximal area fraction of
the gp41 hydrophobic insertions is w~0:42 which results in a total
radius of curvature R~2= fwð Þ&7:5 nm.
Supporting Information
Figure S1 Schematic drawing of gp41 and of the expression
constructs employed to assemble gp41. TRX, thioredoxin fusion
protein; MBP, maltose binding protein; EK, enterokinase cleavage
site and flag sequence.
Found at: doi:10.1371/journal.ppat.1000880.s001 (4.09 MB TIF)
Figure S2 Size exclusion chromatography (SEC) analysis of
gp41. Gp41528-683 elutes from a S200 column at,12 ml similar to
the elution profile of the marker protein aldolase (158 kDa)
consistent with its elongated shape. Notably the previously
determined trimeric core of gp41, gp41(541–665) elutes later at
14.5 ml consistent with a shorter trimeric rod [28][5]. The inset
shows the SDS-PAGE analysis of the complex formed by gp41
peptides containing residues flag-528 to 581 and residues flag-628
to 683.
Found at: doi:10.1371/journal.ppat.1000880.s002 (4.60 MB TIF)
Figure S3 Circular dichroism analysis of gp41 constructs.
Spectra were recorded at room temperature and normalized to
mean residue ellipticity. The presence of MPD in the buffer is
indicated in % (MPD). (A) The helical content of gp41528–683 was
calculated to be 89%. This corresponds well with the crystal
structure, revealing 20 residues out of 126 residues disordered or in
a non-helical conformation. Increasing concentrations of MPD (5,
10 and 40%) did not change the overall helical content. (B) Since
the Tm of gp41528–683 was 87.6uC, we tested whether high MPD
concentrations required for crystal formation might have affected
the interactions within gp41528–683. This showed that MPD
reduced the Tm of gp41528–683 to 82.2uC (5% MPD) and
74.7uC (10% MPD) as well as that of the gp41541–665 core.
Found at: doi:10.1371/journal.ppat.1000880.s003 (5.41 MB TIF)
Figure S4 Model of gp41528–683 membrane association. Resi-
dues Trp 678, Trp 680 and Tyr 681 insert their side chains into
one leaflet of the bilayer, thus inducing local membrane curvature.
The position of the TMR is represented by one TMR (green).
Found at: doi:10.1371/journal.ppat.1000880.s004 (3.06 MB TIF)
Figure S5 Surface representation of trimeric gp41528–683.
Exposed hydrophobic residues are colored in green. Note that
the MPER region forms an extended hydrophobic surface patch.
Found at: doi:10.1371/journal.ppat.1000880.s005 (4.61 MB TIF)
Figure S6 Comparison of the trimeric gp41 MPER with
conformations of MPER peptides. Overlay of the Ca atoms of
the NMR MPER peptide structures (A) (pdb entry 2PV6;
(ELDKWASLWNWFNITNWLWYIK) [17] (shown in cyan)
and (B) pdb entry 1JAV (KWASLWNWFNITNWLWYIK) [37]
(shown in green). Residues recognized by nAb 4E10 are indicated.
Found at: doi:10.1371/journal.ppat.1000880.s006 (2.38 MB TIF)
Figure S7 Overlay of Ca atoms of MPER present in the crystal
structure with the 4E10 peptide complex structure [16]. Side
chains of membrane-embedded MPER are shown as well as
hydrophobic side chains of the 4E10 heavy chain CDR3 region
(shown in salmon). W100 and L100C are oriented in a way that
permits membrane insertion as postulated [18]. W100B whose
orientation is determined by a water mediated polar contact could
contribute to membrane interaction upon flipping sideward.
Found at: doi:10.1371/journal.ppat.1000880.s007 (2.30 MB TIF)
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